Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacological principles for safe benzodiazepine and Z-drug dose reduction.

Psychological medicine·2026
Same author

Benzodiazepine receptor agonist deprescribing principles for long-term use and dependence: modified Delphi recommendations from a multi-disciplinary expert panel.

Therapeutic advances in psychopharmacology·2026
Same author

Concerning the harm-benefit ratio of escitalopram for pediatric generalized anxiety disorder. A critical viewpoint on the evidence and approval process.

The International journal of risk & safety in medicine·2026
Same author

Stopping antidepressants safely.

African journal of primary health care & family medicine·2026
Same author

Supporting General Practitioners to Deprescribe Benzodiazepines and Z-Drugs in Primary Care: Findings From a Modified Delphi Study.

Basic & clinical pharmacology & toxicology·2026
Same author

Peak systolic velocity, not vein size, predicts abnormal sperm count in adolescent Tanner V patients with primary left varicocele.

Journal of pediatric urology·2026

Related Experiment Video

Updated: Sep 1, 2025

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

19.4K

Pediatric Bladder Tumors: A Ten-Year Retrospective Analysis.

Andrew D Shumaker1, Miriam Harel1, Jordan Gitlin1

  • 1Pediatric Urology Associates, P.C. Tarrytown, NY.

Urology
|August 15, 2022
PubMed
Summary

This study reviewed 30 pediatric bladder tumors over 10 years, finding a mix of inflammatory and malignant types. Fortunately, most patients achieved no evidence of disease after treatment, highlighting the importance of understanding pediatric bladder tumor management.

More Related Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Related Experiment Videos

Last Updated: Sep 1, 2025

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models
10:19

Evaluation of Biomaterials for Bladder Augmentation using Cystometric Analyses in Various Rodent Models

Published on: August 9, 2012

19.4K
Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.4K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.6K

Area of Science:

  • Pediatric Urology
  • Oncology
  • Medical Research

Background:

  • Pediatric bladder tumors are rare, with limited existing data on their presentation, management, and natural history.
  • Understanding the spectrum of these tumors is crucial for effective clinical care.

Purpose of the Study:

  • To present a single pediatric urology practice's 10-year experience with bladder tumors in children.
  • To expand knowledge on the presentations, management strategies, and natural history of pediatric bladder tumors.

Main Methods:

  • Retrospective review of electronic medical records from 2011 to 2021.
  • Inclusion criteria focused on bladder tumors, excluding patients with pre-existing bladder conditions.
  • Utilized International Classification of Diseases, Tenth Revision (ICD-10) and Current Procedural Terminology (CPT) codes for patient identification.

Main Results:

  • Thirty pediatric bladder tumors were identified in patients aged 16 months to 19 years.
  • Tumor types included inflammatory subtypes (11), papillomas (4), rhabdomyosarcomas (4), papillary urothelial neoplasms of low malignant potential (3), and others (8).
  • All 30 patients achieved no evidence of disease at the most recent follow-up, with a median follow-up of 19 months.

Conclusions:

  • Pediatric bladder tumors encompass a range from aggressive rhabdomyosarcomas to more common benign urothelial lesions.
  • The majority of identified tumors were of less aggressive subtypes.
  • Knowledge of treatment options and natural history benefits clinicians and parents.